共 10 条
[1]
Prolonged overall survival in gastric cancer patients after adoptive immunotherapy[J]. Guo-Qing Zhang,Hong Zhao,Jian-Yu Wu,Jin-Yu Li,Xiang Yan,Gang Wang,Liang-Liang Wu,Xiao-Gang Zhang,Yi Shao,Yu Wang,Shun-Chang Jiao. World Journal of Gastroenterology. 2015(09)
[2]
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)[J] . Lin Shen,Jin Li,Jianming Xu,Hongming Pan,Guanghai Dai,Shukui Qin,Liwei Wang,Jinwan Wang,Zhenzhou Yang,Yongqian Shu,Ruihua Xu,Lei Chen,Yunpeng Liu,Shiying Yu,Lilian Bu,Yongzhe Piao. Gastric Cancer . 2015 (1)
[3]
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial[J] . Hansjochen Wilke,Kei Muro,Eric Van Cutsem,Sang-Cheul Oh,Gy?rgy Bodoky,Yasuhiro Shimada,Shuichi Hironaka,Naotoshi Sugimoto,Oleg Lipatov,Tae-You Kim,David Cunningham,Philippe Rougier,Yoshito Komatsu,Jaffer Ajani,Michael Emig,Roberto Carlesi,David Ferry,Kumari Chandrawansa,Jonathan
[4]
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial[J] . Charles S Fuchs,Jiri Tomasek,Cho Jae Yong,Filip Dumitru,Rodolfo Passalacqua,Chanchal Goswami,Howard Safran,Lucas Vieira dos Santos,Giuseppe Aprile,David R Ferry,Bohuslav Melichar,Mustapha Tehfe,Eldar Topuzov,John Raymond Zalcberg,Ian Chau,William Campbell,Choondal Sivanandan,Joanna Pikiel,Mi
[5]
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent[J] . Mark Merchant,Xiaolei Ma,Henry R. Maun,Zhong Zheng,Jing Peng,Mally Romero,Arthur Huang,Nai-ying Yang,Merry Nishimura,Joan Greve,Lydia Santell,Yu-Wen Zhang,Yanli Su,Dafna W. Kaufman,Karen L. Billeci,Elaine Mai,Barbara Moffat,Amy Lim,Eileen T. Duenas,Heidi S. Phillips,Hong Xiang,Judy C. Young,George F. Vande Woude,Mark S. Dennis,Dorothea E. Reilly,Ralph H.
[6]
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J] . Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler. Lancet Oncology . 2013 (6)
[7]
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial[J] . Tom Waddell,Ian Chau,David Cunningham,David Gonzalez,Alicia Frances,Clare Okines,Andrew Wotherspoon,Claire Saffery,Gary Middleton,Jonathan Wadsley,David Ferry,Wasat Mansoor,Tom Crosby,Fareeda Coxon,David Smith,Justin Waters,Timothy Iveson,Stephen Falk,Sarah Slater,Clare Peckitt,Yolanda Barbachano.
[8]
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
[J].
INTERNATIONAL JOURNAL OF ONCOLOGY,
2012, 41 (04)
:1297-1304
Masuzawa, Toru
;
Fujiwara, Yoshiyuki
;
Okada, Kaoru
;
Nakamura, Ayumu
;
Takiguchi, Shuji
;
Nakajima, Kiyokazu
;
Miyata, Hiroshi
;
Yamasaki, Makoto
;
Kurokawa, Yukinori
;
Osawa, Ryuji
;
Takeda, Kazuyoshi
;
Yoshida, Koji
;
Tsunoda, Takuya
;
Nakamura, Yusuke
;
Mori, Masaki
;
Doki, Yuichiro
.
[9]
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J] . Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang. The Lancet . 2010 (9742)
[10]
Isolation and culturing of highly polarized primary epithelial cells from normal human stomach (antrum) as spheroid-like vesicles[J] . Hans-Jürgen Boxberger,Michael J. Sessler,Matthias C. Grausam,Horst-Dieter Becker,Thomas F. Meyer. Methods in Cell Science . 1997 (3)